Lidocaine Patch Versus Celecoxib in Pain From Osteoarthritis of the Knee
Public ClinicalTrials.gov record NCT00904605. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Open-Label Study Comparing the Efficacy and Safety of Lidocaine Patch 5% With Celecoxib 200 mg in Patients With Pain From Osteoarthritis of the Knee
Study identification
- NCT ID
- NCT00904605
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 4
- Lead sponsor
- Endo USA Inc., a Keenova Therapeutics Company
- Industry
- Enrollment
- Not listed
Conditions and interventions
Conditions
Interventions
- Lidoderm Drug
- Celecoxib Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 31, 2004
- Primary completion
- Oct 31, 2004
- Completion
- Oct 31, 2004
- Last update posted
- Feb 14, 2010
2004
United States locations
- U.S. sites
- 20
- U.S. states
- 9
- U.S. cities
- 20
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Hueytown | Alabama | — | — |
| Not listed | Mesa | Arizona | — | — |
| Not listed | Oro Valley | Arizona | — | — |
| Not listed | Phoenix | Arizona | — | — |
| Not listed | Carlsbad | California | — | — |
| Not listed | Daytona Beach | Florida | — | — |
| Not listed | Gainesville | Florida | — | — |
| Not listed | Inverness | Florida | — | — |
| Not listed | Melbourne | Florida | — | — |
| Not listed | Miami | Florida | — | — |
| Not listed | Port Orange | Florida | — | — |
| Not listed | Sarasota | Florida | — | — |
| Not listed | Decatur | Georgia | — | — |
| Not listed | Marietta | Georgia | — | — |
| Not listed | New Orleans | Louisiana | — | — |
| Not listed | Bingham Farms | Michigan | — | — |
| Not listed | Clemmons | North Carolina | — | — |
| Not listed | Winston-Salem | North Carolina | — | — |
| Not listed | Duncansville | Pennsylvania | — | — |
| Not listed | Johnstown | Pennsylvania | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00904605, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 14, 2010 · Synced Jul 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00904605 live on ClinicalTrials.gov.